What Semax Does
Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment of adrenocorticotropic hormone. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, it is approved in Russia for the treatment of cognitive disorders, stroke recovery, and peptic ulcers. It is one of the most studied nootropic peptides — with clinical evidence for cognitive enhancement, neuroprotection, and neuroplasticity.
The mechanisms that matter:
- BDNF upregulation — Semax is one of the most potent known pharmacological inducers of brain-derived neurotrophic factor. BDNF drives neuroplasticity — the brain’s ability to form new connections, consolidate learning, and adapt. This is the core mechanism behind Semax’s cognitive benefits
- Dopamine and norepinephrine modulation — increases catecholamine turnover in the prefrontal cortex, improving executive function, attention, working memory, and motivation. This produces the “focus” effect users describe
- NGF modulation — influences nerve growth factor expression, supporting neuronal survival and maintenance. Relevant for neuroprotection and long-term brain health
- Neuroprotection — protects neurons from oxidative stress and excitotoxicity. This is why Semax is used clinically in Russia for stroke recovery — it reduces ischemic damage and promotes functional recovery
- Immune modulation — modulates expression of immune-related genes in the brain (distinct from peripheral immune effects), contributing to neuroinflammation regulation
The BDNF Connection
BDNF is the single most important factor in long-term cognitive health. It promotes:
- Synaptogenesis (new synaptic connections)
- Long-term potentiation (the cellular basis of memory)
- Neuronal survival and resilience to stress
- Hippocampal neurogenesis (new neurons in the memory center)
Exercise, meditation, sleep, and intermittent fasting all increase BDNF. Semax does it pharmacologically — and the magnitude is significant. Animal studies show Semax increases BDNF mRNA expression by 300–500% in the hippocampus and cortex.
This is why Semax’s benefits accumulate over days: BDNF-driven neuroplasticity is not an instant process. Users typically notice effects in the first 1–3 days, with full cognitive benefits emerging over 7–14 days of consistent use.
Semax Variants
Three versions exist, each with increasing potency:
| Variant | Modification | Relative Potency | Duration | Best For |
|---|---|---|---|---|
| Semax | Base peptide | 1x | 3–4 hours | Beginners, general use |
| N-Acetyl Semax (NA-Semax) | Acetyl group added | ~1.5–2x | 4–6 hours | Intermediate users, improved stability |
| N-Acetyl Semax Amidate (NASA-Semax) | Acetyl + amide groups | ~2–3x | 6–8 hours | Experienced users, maximum effect |
The acetyl group improves metabolic stability (resists enzymatic breakdown). The amide group further enhances blood-brain barrier penetration and receptor affinity. Start with base Semax or NA-Semax. Upgrade to NASA only if needed.
Dosing Protocol
Standard Protocol (Base Semax)
| Parameter | Detail |
|---|---|
| Dose | 200–600 mcg per administration |
| Frequency | 1–3 times daily |
| Route | Intranasal |
| Cycle length | 10–30 days on, 10–14 days off |
| Best timing | Morning and early afternoon |
Dose Selection (Base Semax)
| Dose | Use Case |
|---|---|
| 200 mcg | Starting dose, assess response |
| 300–400 mcg | Standard dose — effective for most users |
| 600 mcg | High dose for demanding cognitive tasks or experienced users |
Dose Equivalents for Variants
| Base Semax | NA-Semax | NASA-Semax |
|---|---|---|
| 200 mcg | 100–150 mcg | 75–100 mcg |
| 400 mcg | 200–300 mcg | 150–200 mcg |
| 600 mcg | 300–400 mcg | 200–300 mcg |
Start with the lowest equivalent dose when switching to a more potent variant.
Timing Strategy
- Morning dose — the primary dose. Sets cognitive tone for the day. Best taken 15–30 minutes before mentally demanding work
- Early afternoon dose — extends cognitive benefit through the workday. Take before 3 PM to avoid any impact on sleep
- Pre-study/pre-work dose — some users dose 15–30 minutes before specific cognitive tasks rather than on a fixed schedule
- Avoid evening dosing — while Semax is not a stimulant, the dopamine modulation and mental alertness can interfere with sleep onset
Intranasal Administration
Semax is used almost exclusively via intranasal route — this provides direct access to the brain through the nasal mucosa and olfactory pathway.
Reconstitution for nasal use:
- Reconstitute lyophilized powder with bacteriostatic water
- Transfer to a metered nasal spray bottle (100 mcL per spray)
- For a 5 mg vial reconstituted with 2.5 mL BAC water: concentration = 2,000 mcg/mL. Each 100 mcL spray = 200 mcg.
| Dose (Base Semax) | Sprays (at 200 mcg/spray) |
|---|---|
| 200 mcg | 1 spray (alternate nostrils between doses) |
| 400 mcg | 1 spray per nostril |
| 600 mcg | 1 spray per nostril + 1 spray |
Technique: Same as Selank — tilt head slightly forward, insert nozzle, spray while gently inhaling. Don’t sniff hard. Allow 30 seconds between sprays in the same nostril to let the mucosa absorb.
Storage: Refrigerate at 2–8°C. Reconstituted nasal solution stable for 28 days. Unreconstituted powder is stable at room temperature for months, longer when frozen.
What to Expect
Days 1–3
- Subtle increase in mental clarity and verbal fluency
- Slightly improved focus — less distractibility
- Some users notice improved color perception and sensory clarity (reported anecdotally)
- Mild mood improvement
Days 4–7
- Noticeable cognitive enhancement — ideas come faster, connections form more easily
- Improved working memory — holding more information in mind simultaneously
- Reading comprehension and information processing speed may improve
- Increased motivation for mentally demanding tasks
Days 7–14
- Full cognitive effects — sustained attention, improved learning, better recall
- BDNF-mediated neuroplasticity accumulating
- Some users report vivid dreams (associated with increased hippocampal activity)
- Consistent baseline improvement in cognitive performance
Post-Cycle
- Effects persist for 1–2 weeks after stopping (BDNF effects have inertia)
- Gradual return to baseline over 2–4 weeks
- No withdrawal symptoms
- Cognitive gains from learning during the cycle are retained (you learned faster, the knowledge stays)
What the Research Says
Semax has one of the strongest evidence bases among nootropic peptides:
Stroke recovery (Phase 3): A multicenter randomized controlled trial in acute ischemic stroke patients showed Semax (intranasal, 12 mg/day for 5 days) improved neurological outcomes and reduced disability scores compared to standard care alone. The neuroprotective effect was attributed to BDNF upregulation and reduced excitotoxicity. Published in Zhurnal Nevrologii i Psikhiatrii.
Cognitive enhancement in healthy subjects: Controlled studies showed Semax improved attention, memory, and cognitive processing speed in healthy volunteers after 10-day intranasal courses. Effects were measured using standard neuropsychological tests and confirmed with EEG showing increased theta and alpha coherence (markers of focused cognitive processing).
BDNF and neurotrophin expression: Animal studies demonstrated Semax increases BDNF mRNA by 300–500% and modulates NGF, NT-3, and NT-4 expression in the hippocampus and cortex. These effects peak at 24 hours and are sustained with daily dosing. Published across multiple neuroscience journals.
Gene expression profiling: Microarray studies showed Semax modulates expression of hundreds of genes related to neuroplasticity, immune function, and cellular stress response. The breadth of genomic effects explains why Semax produces wide-ranging cognitive benefits rather than a single isolated effect.
Optic nerve disease: Semax showed benefit in optic nerve atrophy patients — improving visual function and slowing degeneration. This demonstrates its neuroprotective effects extend beyond the CNS cognitive centers.
Semax vs Other Nootropics
| Feature | Semax | Modafinil | Racetams | Caffeine |
|---|---|---|---|---|
| Primary mechanism | BDNF + dopamine | Histamine/orexin | Acetylcholine | Adenosine antagonist |
| Cognitive enhancement | Strong | Moderate (mainly wakefulness) | Moderate | Mild |
| Neuroprotection | Strong (clinical evidence) | None | Weak | None |
| Tolerance | None | Can develop | Minimal | Develops |
| Side effects | Minimal | Headache, insomnia, anxiety | Headache | Jitteriness, insomnia |
| Addiction potential | None | Low | None | Mild |
| Route | Intranasal | Oral | Oral | Oral |
| Prescription needed | No (research peptide) | Yes (Schedule IV) | No | No |
| Best for | Learning, memory, focus | Sleep deprivation, shift work | Memory, verbal fluency | Alertness |
Safety
Side Effects
Semax has an exceptionally clean safety profile:
| Side Effect | Frequency | Notes |
|---|---|---|
| Nasal irritation | ~10% | From BAC water, not the peptide. Transient |
| Mild headache | ~5% | Usually first 1–2 days, resolves |
| Increased emotional sensitivity | ~5% | Some users report feeling emotions more intensely. Usually experienced as positive |
| Hair shedding (rare) | <2% | Reported anecdotally at higher doses. Reversible on discontinuation |
No serious adverse events in clinical trials. No cardiovascular effects. No hepatotoxicity. No hormonal disruption. No appetite changes. No sexual side effects.
Important Notes
Not a stress hormone. Despite being derived from ACTH, Semax does not stimulate cortisol production. The ACTH(4-10) fragment specifically retains the cognitive effects while lacking the adrenal-stimulating activity of full-length ACTH. This has been confirmed in multiple studies showing no cortisol elevation.
Hair loss concern. A small number of users report increased hair shedding, particularly with NASA-Semax at high doses. The mechanism is unclear but may relate to neurotrophin modulation affecting hair follicle cycling. This is uncommon, dose-dependent, and reversible. If noticed, reduce dose or switch to base Semax.
Approved in Russia, not FDA-approved. Available as a research peptide in the US and most Western countries.
Do Not Use If
- Pregnant or breastfeeding (insufficient safety data)
- Under 18 (not studied in pediatric populations)
- History of seizure disorders (theoretical concern with increased neuronal excitability — though no seizures reported in clinical use)
What Comes Next
- Add anxiety reduction — Selank Protocol is the standard complement (GABA modulation + mood)
- Run the full combination — Nootropic Stack (Selank + Semax together)
- Explore other protocols matched to your goals in the Directory
- Use the Reconstitution Calculator for exact dosing math
Frequently Asked Questions
What does Semax do? +
Semax is a synthetic peptide analog of ACTH(4-10) — a fragment of adrenocorticotropic hormone. It enhances cognitive function by upregulating BDNF (brain-derived neurotrophic factor), modulating dopamine and norepinephrine, and providing neuroprotection. Users report improved focus, memory, verbal fluency, and mental endurance. It's approved in Russia for cognitive disorders and stroke recovery.
What is the difference between Semax, NA-Semax, and NASA-Semax? +
Semax is the base peptide (ACTH 4-10 analog). N-Acetyl Semax (NA-Semax) has an acetyl group added for improved stability and slightly enhanced potency. N-Acetyl Semax Amidate (NASA-Semax) has both an acetyl group and an amide group — it's the most potent and longest-lasting variant, roughly 2–3x stronger than base Semax. Start with base Semax or NA-Semax. NASA is for experienced users who want maximum effect.
How does Semax compare to Modafinil? +
Different mechanisms, different effects. Modafinil primarily promotes wakefulness through histamine and orexin pathways — it keeps you awake and alert. Semax enhances cognitive function through BDNF upregulation and dopamine modulation — it makes you think better. Modafinil is better for sleep deprivation and shift work. Semax is better for learning, memory, and sustained cognitive performance. They can be combined, but start each separately first.
Is Semax a stimulant? +
Not technically. Semax doesn't activate stimulant pathways (no adrenergic surge, no increased heart rate). But users report stimulant-like effects — improved focus, increased motivation, greater mental energy. This comes from dopamine and norepinephrine modulation rather than direct stimulation. The effect is cleaner than caffeine or amphetamines — no jitteriness, no crash, no tolerance.
Can I use Semax long-term? +
Semax is typically cycled (10–30 days on, 10–14 days off). Long-term continuous use has been studied for up to 12 months in Russian clinical settings without adverse effects. However, cycling is recommended to maintain optimal receptor sensitivity and to periodically assess cognitive baseline without the peptide.
Does Semax affect mood? +
Yes, positively. Semax increases dopamine and BDNF — both associated with improved mood, motivation, and resilience. Some users describe a subtle mood lift and reduced emotional reactivity. For more direct anxiolytic effects, Selank is the better choice. The Semax + Selank combination addresses both cognition and mood.
Protocol Summary
| Research Dose | 200–600 mcg per dose |
| Frequency | 1–3 times daily |
| Duration | 10–30 day cycles |
| Administration | Intranasal |